DCBT1234-Lung KR

**DCBT1234-Lung KR** is an investigational oral plant-extract formulation studied for **chronic obstructive pulmonary disease**. It contains hydro-alcoholic extracts from *Bryonia alba*, *Cephaelis ipecacuanha*, and *Drosera peltata*. In a six-month randomized, double-blind, placebo-controlled study in 105 patients with COPD, the formulation was evaluated against placebo and oral salbutamol + theophylline + bromhexine, with reported improvements in FEV1, arterial oxygenation, and respiratory symptoms. Its molecular mechanism and direct pharmacological targets have not been established. ([sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S0954611105001769))

Other names

DCBT1234-LungKRDCBT-1234-LungKRDCBT 1234-LungKR